Extrapulmonary Small Cell Carcinoma and Neuroendocrine Carcinoma
1 clinical trials · Condition
◉ Watch Extrapulmonary Small Cell Carcinoma and Neuroendocrine Carcinoma
| Record | Firm | Date |
|---|---|---|
| Tarlatamab for Advanced Extrapulmonary Small Cell Carcinoma and Neuroendocrine Carcinoma (TAURUS) (NCT06816394) | National Taiwan University Hospital | 2025-05-15 |
Track Extrapulmonary Small Cell Carcinoma and Neuroendocrine Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.